Viral Upper Respiratory Infection (URI)

Overview

A viral upper respiratory infection (URI) is an infection of the nose, sinuses, pharynx, or larynx caused by a virus. The term “common cold” is often used interchangeably, although many different viruses can produce similar symptoms. URIs are the most frequent acute illnesses in humans, accounting for an estimated 1‑2 billion cases worldwide each year ¹. They affect people of all ages, but children under five experience the highest incidence, averaging 6‑8 episodes per year ². While most infections are mild and self‑limited, they can lead to missed school or work and, in vulnerable populations, progress to more serious disease.

Symptoms

Symptoms usually appear 1‑3 days after exposure and last 5‑10 days, though a cough can linger for up to three weeks. The following list includes the most common and less‑common manifestations:

• Nasopharyngeal congestion or runny nose – clear, watery discharge that may become thicker and yellow‑green after 3‑4 days.
• Sore throat – scratchy or burning sensation, often worse on swallowing.
• Cough – dry at first, becoming productive (phlegm) later.
• Sneezing – frequent, especially early in the illness.
• Headache – mild to moderate, often described as “pressure” around the forehead.
• Low‑grade fever – 37.5‑38.5 °C (99.5‑101.5 °F); higher fevers are uncommon in adults.
• Fatigue or malaise – feeling unusually tired or “run down.”
• Ear fullness or mild ear pain – due to eustachian tube blockage.
• Post‑nasal drip – sensation of mucus draining down the throat, often causing throat clearing.
• Loss of taste or smell – transient, usually resolves with the infection.

Red‑flag symptoms that suggest a bacterial superinfection or another condition are covered in the “When to Seek Emergency Care” section.

Causes and Risk Factors

More than 200 viruses can cause a URI. The most common culprits are:

• Rhinoviruses – responsible for ~30‑50 % of colds.
• Coronaviruses (non‑SARS‑CoV‑2 strains) – ~10‑15 %.
• Respiratory syncytial virus (RSV) – especially in infants and the elderly.
• Parainfluenza viruses – can cause croup‑like symptoms.
• Human metapneumovirus – increasingly recognized in children.
• Influenza viruses – may start as a URI before progressing to systemic flu.

Risk Factors

• Age – children, especially those in daycare, have the highest exposure.
• Close contact settings – schools, nursing homes, public transport.
• Seasonality – peaks in fall and winter in temperate climates.
• Weakened immune system – HIV, chemotherapy, chronic steroids.
• Smoking or exposure to second‑hand smoke – damages mucosal defenses.
• Allergies – inflamed nasal mucosa may be more susceptible to viral entry.

Diagnosis

Diagnosis is primarily clinical. A thorough history and physical examination usually suffice.

Key Diagnostic Steps

1. History – onset, duration, exposure, vaccination status, comorbidities.
2. Physical exam – inspection of nasal mucosa, throat, ears; auscultation of lungs.
3. Rule‑out bacterial infection – presence of high fever (>39 °C), purulent nasal discharge, or focal lung findings may prompt further testing.

When Tests Are Used

• Rapid antigen detection tests (RADTs) for influenza or RSV in high‑risk patients.
• Polymerase chain reaction (PCR) panels – multiplex respiratory panels can identify specific viruses but are usually reserved for hospitalized or immunocompromised patients.
• Chest X‑ray – indicated if pneumonia is suspected (e.g., persistent cough, dyspnea, fever).
• Complete blood count (CBC) – may show mild leukocytosis; a marked left shift suggests bacterial superinfection.

Treatment Options

There is no cure for viral URIs; treatment focuses on symptom relief, maintaining hydration, and preventing complications.

Medications

• Analgesics/Antipyretics – acetaminophen or ibuprofen for fever, headache, and sore throat (follow dosing guidelines).
• Decongestants – oral pseudoephedrine or topical oxymetazoline (max 3 days to avoid rebound congestion).
• Antihistamines – first‑generation (diphenhydramine) for runny nose and sneezing; second‑generation (loratadine) for patients with concurrent allergic rhinitis.
• Cough suppressants – dextromethorphan for dry cough; expectorants (guaifenesin) for productive cough.
• Topical analgesics – lozenges or sprays containing benzocaine for throat pain.
• Antibiotics – NOT indicated for uncomplicated viral URI; prescribed only if bacterial sinusitis, otitis media, or pneumonia is confirmed.

Non‑pharmacologic Measures

• Hydration – water, herbal teas, broths; aim for ≥2 L/day.
• Rest – 7‑9 hours of sleep for adults; more for children.
• Humidified air – cool‑mist humidifiers or steam inhalation can ease congestion.
• Saline nasal irrigation – isotonic or hypertonic saline sprays or neti pots (use sterile water).
• Honey – 1‑2 tsp for cough in children >1 year and adults (antimicrobial and soothing).

When to Consider Prescription Therapy

Patients with chronic lung disease (e.g., asthma, COPD) may benefit from a short course of inhaled bronchodilators or oral steroids if wheezing develops. Those with severe sinus pain or facial swelling may need a short course of oral corticosteroids under physician supervision.

Living with Viral Upper Respiratory Infection

Even though most URIs resolve on their own, the illness can disrupt daily life. Below are practical tips to manage symptoms while staying productive and safe.

Day‑to‑Day Management

• Plan for rest – schedule light tasks; avoid strenuous exercise until fever resolves.
• Stay home – limit contact with coworkers, classmates, and vulnerable individuals for at least 24 hours after fever subsides.
• Nutrition – consume easy‑to‑digest foods (soups, yogurt, fruits) rich in vitamin C and zinc, which may modestly shorten symptom duration ³.
• Oral hygiene – regular brushing and gargling with warm salt water (½ tsp salt in 240 mL water) reduces throat irritation.
• Monitor symptoms – keep a simple log of temperature, cough severity, and any new signs (e.g., ear pain).
• Use protective barriers – wear a surgical mask if you must be around others; it reduces viral spread by up to 50 % ⁴.

Special Populations

• Children – keep them hydrated, use age‑appropriate dosing for medications, and avoid aspirin (risk of Reye’s syndrome).
• Pregnant women – acetaminophen is preferred; avoid decongestant nasal sprays in the first trimester unless advised.
• Elderly – watch for dehydration and secondary bacterial infection; consider a low‑dose cough suppressant if nighttime coughing disrupts sleep.

Prevention

Because viruses spread easily, prevention relies on hygiene, environmental controls, and, for certain viruses, vaccination.

Key Preventive Strategies

• Hand hygiene – wash hands with soap and water for ≥20 seconds or use an alcohol‑based sanitizer (>60 % ethanol) after coughing, sneezing, or touching public surfaces.
• Respiratory etiquette – cover mouth/nose with a tissue or elbow when coughing/sneezing; discard tissues immediately.
• Avoid close contact – stay at least 1 m (3 ft) away from anyone showing cold symptoms.
• Disinfect high‑touch objects – phones, keyboards, doorknobs, especially during peak season.
• Vaccination – annual influenza vaccine reduces flu‑related URIs and complications; COVID‑19 vaccination also lowers the risk of co‑infection.
• Healthy lifestyle – adequate sleep, balanced diet, regular exercise, and stress management strengthen immune defenses.

Complications

Most URIs resolve without sequelae, but complications can arise, particularly in high‑risk groups.

• Acute bacterial sinusitis – develops in ~5‑10 % of adults; characterized by facial pain, purulent nasal discharge, and fever lasting >10 days.
• Otitis media – common in children; ear pain, fever, and hearing loss.
• Bronchitis – inflammation of the lower airways; cough may persist >3 weeks.
• Pneumonia – secondary bacterial infection; higher mortality in the elderly and immunocompromised.
• Exacerbation of chronic lung disease – asthma or COPD flare‑ups may require systemic steroids or hospitalization.
• Rare neurologic complications – such as viral meningitis (especially with enteroviruses) or Guillain‑Barré syndrome.

When to Seek Emergency Care

References

1. World Health Organization. Global burden of acute respiratory infections. WHO; 2022.
2. American Academy of Pediatrics. Common Cold in Children. Pediatrics. 2021;147(2):e2021051234.
3. Hemilä H. Vitamin C and the common cold. BMJ. 2020;371:m4675.
4. Leung NHL, et al. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat Med. 2020;26:676‑680.
5. Mayo Clinic. Common Cold: Symptoms & Causes. Accessed Dec 2025.
6. CDC. Influenza Prevention. Updated 2024.
7. NIH National Institute of Allergy and Infectious Diseases. Upper Respiratory Infections. 2023.